Educational Webinars
ACT sponsors quarterly webinars on current topics in toxicology, including primarily drug and chemical safety assessments. Presenters are experts in their field, with backgrounds in government, industry or academia. The goal of the webinar series is to provide accessible education on topics in toxicology to ACT members and, more broadly, members of the toxicology community worldwide. ACT Webinars are reaching thousands, with collaborations spanning the globe while increasing individual and corporate ACT membership and participation. The ACT Signature Webinars are approximately 90 minutes, which includes questions and answers.
Upcoming Webinar
Realizing the Full Potential of Membership with the American College of Toxicology
Hosted by American College of Toxicology, presented by the Early Career Professional Subcommittee
Moderated by Katherine Duke and Benjamin A. Elser
Releasing December 16, 2019
View Abstract 
|
|
The History of ACT
Speaker: David G. Serota, PhD, DABT
ACT CHARGE40 Working Group Chair
7th Inning Stretch Consulting, LLC
More information about Dr. Serota 
Dr. Dave Serota was employed in the CRO industry for 40 years as both a study director and corporate leader, retiring from MPI Research in 2016 as Senior Vice President and Director of Research. Following his retirement, he created the consulting organization, 7th Inning Stretch Consulting LLC, which supports sponsors conducting preclinical toxicology testing. He joined ACT in 1981 and has held many appointed and elected positions including Membership Committee (2004–06), Councilor (2007–09), Vice President (2010), President-elect (2011), President (2012), Past President (2013) Resource Committee Chair (2013–14), Endowment Committee (2015), and chair of the CHARGE40 Working Group (2018–19). In 2015, he was the recipient of the ACT Service Award.
|
|
Membership and Mentorship Program
Speaker: William B. Mattes, PhD, DABT
2018–19 ACT Membership Committee Chair, Division of Systems Biology National Center for Toxicological Research, US FDA
More information about Dr. Mattes
Dr. Bill Mattes is the director of the Division of Systems Biology, part of the FDA’s National Center for Toxicological Research. He has also been an independent consultant, director of C-Path’s Predictive Safety Testing Consortium (PSTC) and held various positions in biotech (Gene Logic) and pharma (Phamacia, Ciba Geigy). He is a diplomate of the American Board of Toxicology, and has been a Full member of the American College of Toxicology (ACT) since 2007. He has served on the ACT Website Committee (2012–14), the Program Committee and has been on Council (2018–20). He currently fills the guitar chair for Jazzicology at the ACT Annual Meeting.
|
|
Educational Opportunities
Speaker: Grace M. Furman, PhD, DABT
2018–2019 ACT Councilor and Education Committee Chair, Paracelsus, Inc.
More information about Dr. Grace Furman
Dr. Grace Furman has been an independent consultant since 2007 and a Full member of ACT since 2000. Since joining the College, Grace has held several elected positions including Nominating Committee member (2008), Councilor (first term; 2009–11), Secretary (2013–14), Councilor (second term; 2017–20) and Education Committee Co-Chair (2017–18). Grace is currently the Chair of the 2019 Education Committee and an ex officio member of the 2019 Program Committee. In addition, Grace participates as a mentor in the ACT Mentorship Program.
|
|
Annual Meeting
Speaker: David R. Compton, PhD, DABT
2018–19 ACT President, Sanofi US
More information about Dr. David Compton
Dr. David Compton has over 30 years of professional experience, having had careers as a university professor, as a CRO safety pharmacologist and toxicology Study Director, and as a toxicologist in the pharmaceutical industry. He received the Students’ Choice Award for Faculty of the Year in 1994, and during this academic period published 60 manuscripts (14 first author) and co-authored 7 book chapters (5 first author). While working in industry Dave was Editor and chapter author of a book published in 2015 (Nonclinical Assessment of Abuse Potential for New Pharmaceuticals). David has been Full member of ACT since 1998, and was first certified as a Diplomate of the American Board of Toxicology (DABT) in 1999. David has served multiple roles within ACT in the last 12 of his 21-year membership: Nominating Committee (2007–08); Symposium Organizer/Chair/Speaker (2008); Chair, ACT 30th Anniversary Celebration Committee (2008–09); Awards Committee (2008-10); Council term (1st term; Dec 2010 to Nov 2013); Chair, ad hoc Website Committee (Jan 2013 to Dec 2014); Council (2nd term; Dec 2013 to Nov 2016); Symposium Organizer/Chair (2016); Vice President (2016–17); President-elect (2017–18); and President (2018–19) with duties as Past-President to be served (2019–20). David is a member of the Editorial Board of International Journal of Toxicology (2012 to present).
|
Registration is not required for this webinar.
|
Archives/Past Webinars
View ACT’s Past Signature Webinars ▸
Scientific Liaison Coalition (SLC) Webinars
View Webinars ▸
= Members Only
